Elekta AB ser. B
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear accelerator and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo that delivers offline and online adaptive radiation therapy; Elekta Versa … Read more
Elekta AB ser. B (0O5H) - Total Liabilities
Latest total liabilities as of October 2021: Skr15.70 Billion SEK
Based on the latest financial reports, Elekta AB ser. B (0O5H) has total liabilities worth Skr15.70 Billion SEK as of October 2021.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Elekta AB ser. B - Total Liabilities Trend (2017–2021)
This chart illustrates how Elekta AB ser. B's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Elekta AB ser. B Competitors by Total Liabilities
The table below lists competitors of Elekta AB ser. B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Xinjiang Daqo New Energy Co Ltd
SHG:688303
|
China | CN¥3.49 Billion |
|
Sinotruk Jinan Truck Co Ltd
SHE:000951
|
China | CN¥28.75 Billion |
|
AXT Inc
NASDAQ:AXTI
|
USA | $99.12 Million |
|
Foschini Group Ltd (The)
PINK:FHHGF
|
USA | $36.01 Billion |
|
Trainline Plc
PINK:TNLIF
|
USA | $377.51 Million |
|
NCsoft Corp
KO:036570
|
Korea | ₩931.88 Billion |
|
The Foschini Group Limited
PINK:FHNGY
|
USA | $36.01 Billion |
|
Peloton Interactive Inc
NASDAQ:PTON
|
USA | $2.49 Billion |
Liability Composition Analysis (2017–2021)
This chart breaks down Elekta AB ser. B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.08 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.93 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.66 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Elekta AB ser. B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Elekta AB ser. B (2017–2021)
The table below shows the annual total liabilities of Elekta AB ser. B from 2017 to 2021.
| Year | Total Liabilities | Change |
|---|---|---|
| 2021-04-30 | Skr16.65 Billion | -17.99% |
| 2020-04-30 | Skr20.30 Billion | +24.64% |
| 2019-04-30 | Skr16.29 Billion | -2.90% |
| 2018-04-30 | Skr16.77 Billion | +18.32% |
| 2017-04-30 | Skr14.18 Billion | -- |